论文部分内容阅读
Antidepressants selectively inhibiting serotonin reuptake(SSRIs)represent a highly-effective drug class,and novel therapeutic strategies were proposed to improve SSRIs' drug efficacy.The inhibitory mechanism of FDA approved SSRIs could provide great insights and act as important starting points to discover privileged drug scaffold with improved efficacy.